LGND Insider Trading Activity and SEC Form 4 Filings
Trump's trades in LGND
From his financial disclosures
-
0 purchases
$15K+
1 sale
Sale
May 15, 2026
Reported 47d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
LGND insider trading summary
Over the past 12 months, insiders at Ligand Pharmaceuticals Inc (LGND) reported 146 sales worth $36.3M by 9 insiders and no open-market purchases on SEC Form 4. Net insider selling was $36.3M.
Latest LGND insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Jason Aryeh | Director | Sell | $90K (282 @ $319.99) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $126K (403 @ $313.75) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $152K (490 @ $310.61) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $87K (283 @ $307.39) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $198K (634 @ $312.85) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $162K (520 @ $311.72) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $218K (708 @ $308.43) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $162K (522 @ $309.91) |
| Nov 2, 2026 | Jason Aryeh | Director | Sell | $224K (700 @ $320.43) |
| Nov 2, 2026 | Andrew Reardon | CLO & Secretary | Sell | $25K (80 @ $314.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.